Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Cantor Fitzgerald / Glancy Prongay & Murray

Cantor Fitzgerald & Glancy Prongay & Murray

2 shared events · Importance 3 · Last updated Aug 17, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (2)
35
Regulatory
ADMA Biologics Securities Class Action
Cantor Fitzgerald: Cantor Fitzgerald downgraded ADMA Biologics stock from Overweight to Neutral following the Culper Research report.
Glancy Prongay & Murray: Glancy Prongay & Murray is involved in the class action, reminding investors of the deadline and seeking lead plaintiff roles. It stands to gain from the litigation.
Jun 14, 2026 · 294 articles
24
Regulatory
Capricor Deramiocel FDA Setback Securities Class Actions
Cantor Fitzgerald: Analyst firm that published a negative note on the FDA briefing documents.
Glancy Prongay & Murray: Filed a class action lawsuit against Capricor.
Jul 27, 2026 · 293 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Cantor Fitzgerald and Glancy Prongay & Murray interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.